| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647246 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 9 Pages |
Abstract
BAT identified patients allergic to platinum compounds with an increased risk of reactions during desensitization and higher CD63 expression was observed in severe reactions. Multiple RDDs to platinum compounds did not induce persistent hyporesponsiveness on basophils. BAT is a potential biomarker for RDD.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Pedro MD, PhD, Violeta Régnier MD, Matthieu MD, Joana MD, Mariana C. MD, PhD,